by Sue Robbins | Feb 25, 2021 | Migraine
People with migraine disease have seen more positive developments in the last three years than we’ve seen in decades, with new classes of preventive and acute treatments, new devices, increased public awareness and support, and more research and development. Although...
by Sue Robbins | Nov 2, 2020 | Migraine
Treatment with fremanezumab, the fully humanized IgG2?a monoclonal antibody that selectively targets calcitonin gene-related peptide, significantly reduced the number of headache or migraine days experienced before therapy. These findings, from a pooled analysis of...
by Sue Robbins | Aug 20, 2020 | Migraine
Predictors of chronic migraine Recent data from a systematic review and meta-analysis point to clinical and sociodemographic factors associated with migraine chronification INTERNATIONAL HEADACHE SOCIETY London, UK: A meta-analysis published in the...
by Sue Robbins | Aug 13, 2020 | Migraine
I was sitting in my neurologist’s office, as my doctor and I reviewed the long list of things we’d already tried to treat my chronic migraine—supplements and hard-to-pronounce drugs, abortive and preventative medications, near-misses and...
by Sue Robbins | Jul 15, 2020 | Migraine
Compared with healthy control participants, pediatric patients with chronic migraine (CM) report a higher rate of depression, according to study findings published in Pediatric Neurology. Researchers suggested that clinicians should consider including therapy in...
